Cem Gabay

37.5k total citations · 8 hit papers
287 papers, 22.0k citations indexed

About

Cem Gabay is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Cem Gabay has authored 287 papers receiving a total of 22.0k indexed citations (citations by other indexed papers that have themselves been cited), including 144 papers in Rheumatology, 115 papers in Immunology and 54 papers in Hematology. Recurrent topics in Cem Gabay's work include Rheumatoid Arthritis Research and Therapies (115 papers), Systemic Lupus Erythematosus Research (59 papers) and Autoimmune and Inflammatory Disorders Research (53 papers). Cem Gabay is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (115 papers), Systemic Lupus Erythematosus Research (59 papers) and Autoimmune and Inflammatory Disorders Research (53 papers). Cem Gabay collaborates with scholars based in Switzerland, United States and France. Cem Gabay's co-authors include Irving Kushner, Gaby Palmer, William P. Arend, Céline Lamacchia, Axel Finckh, Dominique Talabot‐Ayer, Carla Guthridge, Mark Malyak, Praxedis Martin and Sylvette Bas and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Cem Gabay

272 papers receiving 21.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acute-Phase Proteins and Other Systemic Responses to Inflammation

1999 5.2k citations Cem Gabay et al. profile →
Interleukin-6 and chronic inflammation.

2006 1.1k citations Cem Gabay Arthritis Research & Therapy profile →
INTERLEUKIN-1 RECEPTOR ANTAGONIST: Role in Biology

1998 848 citations William P. Arend, Cem Gabay et al. profile →
IL‐1, IL‐18, and IL‐33 families of cytokines

2008 706 citations William P. Arend, Gaby Palmer et al. profile →
IL-1 pathways in inflammation and human diseases

2010 700 citations Cem Gabay, Gaby Palmer et al. profile →
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

2013 502 citations Cem Gabay, Paul Emery et al. The Lancet profile →
Prevotella copri in individuals at risk for rheumatoid arthritis

2019 312 citations D. Alpizar-Rodriguez, Cem Gabay et al. Annals of the Rheumatic Diseases profile →
Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome

2018 261 citations Charlotte Girard, Cem Gabay et al. profile →

Peers

Countries citing papers authored by Cem Gabay

Since Specialization

Citations

This map shows the geographic impact of Cem Gabay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cem Gabay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cem Gabay more than expected).

Fields of papers citing papers by Cem Gabay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cem Gabay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cem Gabay. The network helps show where Cem Gabay may publish in the future.

Co-authorship network of co-authors of Cem Gabay

This figure shows the co-authorship network connecting the top 25 collaborators of Cem Gabay. A scholar is included among the top collaborators of Cem Gabay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cem Gabay. Cem Gabay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care 2023 ·Scientific Reports ·Myriam Riek, Almut Scherer, Burkhard Möller, Adrian Ciurea, (unknown), Cem Gabay, Diego Kyburz, Laure Brulhart, Johannes von Kempis, Ruediger B. Müeller, Paul Hasler, (unknown), (unknown), Pascal Zufferey, Jean Dudler, Axel Finckh	2
2	The cytosolic DNA sensor AIM2 promotes Helicobacter‐induced gastric pathology via the inflammasome 2023 ·Immunology and Cell Biology ·(unknown), Virginie Deswaerte, Alison C. West, (unknown), (unknown), (unknown), Beena Kumar, Emiliana Rodriguez, Cem Gabay, Richard L. Ferrero, Brendan J. Jenkins	9
3	Excess Serum Interleukin‐18 Distinguishes Patients With Pathogenic Mutations in PSTPIP1 2021 ·Arthritis & Rheumatology ·Deborah L. Stone, Amanda K. Ombrello, Juan I. Aróstegui, Corinne Schneider, Vinh Dang, Adriana de Jesus, Charlotte Girard, Cem Gabay, Wonyong Lee, Jae Jin Chae, Ivona Aksentijevich, Raphaela Goldbach‐Mansky, Daniel L. Kastner, Scott Canna	25
4	Ultrasound is not associated with the presence of systemic autoimmunity or symptoms in individuals at risk for rheumatoid arthritis 2019 ·RMD Open ·Laure Brulhart, D. Alpizar-Rodriguez, (unknown), Pascal Zufferey, (unknown), (unknown), Ilias Lazarou, Cem Gabay, Axel Finckh	15
5	Inflammasome Adaptor ASC Suppresses Apoptosis of Gastric Cancer Cells by an IL18-Mediated Inflammation-Independent Mechanism 2017 ·Cancer Research ·Virginie Deswaerte, Paul M. Nguyen, Alison C. West, (unknown), Liang Yu, Saleela M. Ruwanpura, Jesse J. Balic, (unknown), Charlotte Girard, Adele Preaudet, Hiroko Oshima, Ka Yee Fung, Hazel Tye, Meri Najdovska, Matthias Ernst, Masanobu Oshima, Cem Gabay, Tracy L. Putoczki, Brendan J. Jenkins	66
6	IL-38 overexpression induces anti-inflammatory effects in mice arthritis models and in human macrophages in vitro 2017 ·Annals of the Rheumatic Diseases ·Marie‐Astrid Boutet, Aurélie Najm, Géraldine Bart, Régis Brion, S. Touchais, Valérie Trichet, Pierre Layrolle, Cem Gabay, Gaby Palmer, Frédéric Blanchard, Benoît Le Goff	105
7	IL-36–Induced Toxicity in Neonatal Mice Involves TNF-α Production by Liver Myeloid Cells 2016 ·The Journal of Immunology ·Jennifer Palomo, Béatris Mastelic-Gavillet, Estelle Woldt, (unknown), Emiliana Rodriguez, Gaby Palmer, Claire‐Anne Siegrist, Cem Gabay	6
8	The Effect of Comedication With a Conventional Synthetic Disease‐Modifying Antirheumatic Drug on Drug Retention and Clinical Effectiveness of Anti–Tumor Necrosis Factor Therapy in Patients With Axial Spondyloarthritis 2016 ·Arthritis & Rheumatology ·Michael J. Nissen, Adrian Ciurea, Jürg Bernhard, Giorgio Tamborrini, Ruediger B. Müeller, (unknown), (unknown), Pascale Exer, Cem Gabay, Axel Finckh	21
9	Consensus guidelines on the cardiovascular risk management in patients with rheumatoid arthritis 2015 ·Cardiovascular Medicine ·François Mach, Cem Gabay, Nicolas C. Buchs, Jean Dudler, Bariş Gencer, Paul Hasler, Christian M. Matter, (unknown), Johannes von Kempis, Pascal Zufferey	1
10	Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics 2014 ·Arthritis Research & Therapy ·Glynn Dennis, Cécile Holweg, Sarah Kummerfeld, David F. Choy, Audi Setiadi, Jason A. Hackney, Peter M. Haverty, Houston Gilbert, Wei Lin, Lauri Diehl, Sven Fischer, (unknown), David Musselman, Micki Klearman, Cem Gabay, Arthur Kavanaugh, Judith Endres, David A. Fox, Flavius Martin, Michael J. Townsend	265
11	Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial (vol 381, pg 1541, 2013) 2013 ·The Lancet ·Cem Gabay, P. Emery, Ronald van Vollenhoven	13
12	Seropositivity and response to RTX: Data from the CERERRA collaboration 2012 ·Annals of the Rheumatic Diseases ·Katerina Chatzidionysiou, E. Lie, (unknown), (unknown), Merete Lund Hetland, Ulrik Tarp, I. Ancuta, Karel Pavelká, (unknown), Cem Gabay, Helena Canhão, Matija Tomšič, P. Van Riel, Juan J. Gómez‐Reino, T.K. Kvien, Ronald van Vollenhoven	0
13	Synovial Fluid Leptin Level Is Associated with Residual Pain and Functional Disability One Year After Total Joint Arthroplasty 2012 ·Arthritis & Rheumatism ·(unknown), Gábor J. Puskás, Axel Finckh, Domizio Suvà, (unknown), Cem Gabay, Daniel Fritschy, Pierre Hoffmeyer	0
14	Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement 2012 ·Annals of the Rheumatic Diseases ·Monika Schoels, Désirée van der Heijde, Ferdinand C. Breedveld, Gerd R Burmester, Maxime Dougados, Paul Emery, Gianfranco Ferraccioli, Cem Gabay, Allan Gibofsky, Juan J. Gómez‐Reino, Graeme Jones, Tore K. Kvien, (unknown), Norihiro Nishimoto, Josef S Smolen	73
15	Efficacy of different doses of rituximab for the treatment of rheumatoid arthritis: Data from the CERERRA collaboration. 2011 ·Research at the University of Copenhagen (University of Copenhagen) ·Katerina Chatzidionysiou, Elisabeth Lie, Е. Л. Насонов, G. Lukina, Merete Lund Hetland, Ulrik Tarp, I. Ancuta, Karel Pavelká, Dan Nordström, Cem Gabay, Helena Canhão, Matija Tomšič, (unknown), Juan J. Gómez‐Reino, Tore K Kvien, Ronald van Vollenhoven	1
16	Adaptive Immune Response in JAM-C-Deficient Mice: Normal Initiation but Reduced IgG Memory 2009 ·The Journal of Immunology ·(unknown), Boris P.-L. Lee, Gaby Palmer, Cem Gabay, Ralf H. Adams, Michel Aurrand‐Lions, Beat A. Imhof	13
17	Indirect Effects of Leptin Receptor Deficiency on Lymphocyte Populations and Immune Response in db/db Mice 2006 ·The Journal of Immunology ·Gaby Palmer, Michel Aurrand‐Lions, Emmanuel Contassot, Dominique Talabot‐Ayer, (unknown), Christian Vesin, Véronique Chobaz-Péclat, Nathalie Busso, Cem Gabay	68
18	Leptin Signaling Deficiency Impairs Humoral and Cellular Immune Responses and Attenuates Experimental Arthritis 2002 ·The Journal of Immunology ·Nathalie Busso, Alexander So, Véronique Chobaz-Péclat, (unknown), Eduardo Martínez-Soria, Dominique Talabot‐Ayer, Cem Gabay	275
19	Talalgies plantaires : aspects cliniques et pratiques 2002 ·Revue Médicale Suisse ·Thierry Fulpius, Cem Gabay	1
20	Commentary Physiologic role of interleukin-1 receptor antagonist 2000 ·William P. Arend, Cem Gabay	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact